Skip to main content
Terug
PRVA logo

Privia Health Group, Inc.

Datakwaliteit: 100%
PRVA
NASDAQ Healthcare Medical - Healthcare Information Services
€ 21,03
▼ € 0,49 (-2,28%)
Marktkapitalisatie: 2,60B
Dagbereik
€ 20,87 € 21,24
52-Weeksbereik
€ 18,77 € 26,51
Volume
671.126
50D / 200D Gem.
€ 22,70 / € 22,86
Vorige Slotkoers
€ 21,52

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (627 peers)

Metriek Aandeel Sector Mediaan
P/E 113,5 0,3
P/B 0,0 2,9
ROE % 0,0 3,7
Net Margin % 1,1 3,8
Rev Growth 5Y % 21,8 10,0
D/E 0,0 0,2

Koersdoel Analisten

Hold
€ 31,00 +47.4%
Low: € 22,00 High: € 36,00
Forward K/W
60,8
Forward WPA
€ 0,35
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,4 B

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2030 € 0,95
€ 0,91 – € 0,99
 3,4 B 1
FY2029 € 0,79
€ 0,76 – € 0,83
 3,1 B 1
FY2028 € 0,65
€ 0,51 – € 0,87
 2,9 B 5

Belangrijkste Punten

Revenue grew 21,75% annually over 5 years — strong growth
Earnings grew 59,33% over the past year
ROE of 0,01% is below average
Debt/Equity of 0,01 — conservative balance sheet
Generating 162,20M in free cash flow
P/E of 113,49 — premium valuation

Groei

Revenue Growth (5Y)
21,75%
Revenue (1Y)22,26%
Earnings (1Y)59,33%
FCF Growth (3Y)41,80%

Kwaliteit

Return on Equity
0,01%
ROIC0,00%
Net Margin1,08%
Op. Margin1,61%

Veiligheid

Debt / Equity
0,01
Current Ratio1,60
Interest Coverage0,00

Waardering

P/E Ratio
113,49
P/B Ratio0,00
EV/EBITDA-13657,16
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 22,26% Revenue Growth (3Y) 13,16%
Earnings Growth (1Y) 59,33% Earnings Growth (3Y) -0,35%
Revenue Growth (5Y) 21,75% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,12B Net Income (TTM) 22,92M
ROE 0,01% ROA 0,00%
Gross Margin 9,40% Operating Margin 1,61%
Net Margin 1,08% Free Cash Flow (TTM) 162,20M
ROIC 0,00% FCF Growth (3Y) 41,80%
Safety
Debt / Equity 0,01 Current Ratio 1,60
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio 113,49 P/B Ratio 0,00
P/S Ratio 1,23 PEG Ratio 2,17
EV/EBITDA -13657,16 Dividend Yield 0,00%
Market Cap 2,60B Enterprise Value -467,55B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,12B 1,74B 1,66B 1,36B 966,22M
Net Income 22,92M 14,39M 23,08M -8,59M -188,23M
EPS (Diluted) 0,18 0,11 0,19 -0,11 -1,77
Gross Profit 199,52M 176,85M 161,50M 134,78M 63,66M
Operating Income 34,24M 16,98M 20,65M -19,12M -217,44M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,37T 1,14B 999,90M 792,81M 686,37M
Total Liabilities 578,44B 452,34M 392,51M 273,76M 236,19M
Shareholders' Equity 737,22B 635,18M 561,44M 499,09M 426,87M
Total Debt 9,53B 5,59M 8,29M 11,50M 46,50M
Cash & Equivalents 479,69B 491,15M 389,51M 347,99M 320,58M
Current Assets 911,00B 834,82M 700,80M 551,96M 446,68M
Current Liabilities 568,52B 449,15M 386,95M 264,27M 190,46M

Strategiescores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#754 of 1052
34
Custom Deep Value Investing (Seth Klarman)
#822 of 827
2

Recente Activiteit

Ingestapt Cash Flow Compounder
Mar 24, 2026
Ingestapt Deep Value Investing (Seth Klarman)
Mar 24, 2026